Sort
15,842 grants matching “pancreatic cancer”
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
$76,984Rebekah White · University Of California, San Diego · R01 · FY2022 · CA
Experimental Tumor Model Shared Resource
$76,809Barbara A Foster · Roswell Park Cancer Institute Corp · P30 · FY2023 · CA
Pancreatic cancer survival analysis with SEER and active follow-up in SF Bay Area
$76,792Elizabeth A. Holly · University Of California, San Francisco · R03 · FY2006 · CA
Potential Role of pp72syk in Pancreatic Adenocarcinoma
$76,771University Of California San Diego · R03 · FY2004 · CA
Investigating the connection between aberrant R-loop formation and genome instability
$76,756Talysa C Viera · University Of California At Davis · F32 · FY2024 · GM
Nrf2 a new therapeutic target for human pancreatic ductal adenocarcinoma.
$76,750Insoo Bae · Georgetown University · R03 · FY2010 · CA
Combining Immunotherapy with Urolithin A to Improve Pancreatic Cancer Survival
$76,750Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R03 · FY2021 · CA
Combining Immunotherapy with Urolithin A to Improve Pancreatic Cancer Survival
$76,750Nagaraj S. Nagathihalli · University Of Miami School Of Medicine · R03 · FY2020 · CA
THE ROLE OF CALCIUM SIGNALING ON PTEN REGULATION
$76,725Yip Chow · University Of California, San Diego · R03 · FY2011 · DK
NCI Diversity Supplement
$76,543Fan Zhang · University Of Florida · R21 · FY2024 · CA
Role of atypical PKCs in Pancreatic Tumor Growth and Metastasis
$76,500Nicole R Murray · Mayo Clinic Jacksonville · R03 · FY2009 · CA
Carbidopa as an inhibitor of the TrpT/ID01 functional complex: A novel immunotherapy agent
$76,500Yangzom Doma Bhutia · Texas Tech University Health Scis Center · R03 · FY2020 · CA
Carbidopa as an inhibitor of the TrpT/ID01 functional complex: A novel immunotherapy agent
$76,500Yangzom Doma Bhutia · Texas Tech University Health Scis Center · R03 · FY2019 · CA
Cadmium, K-ras, and Pancreatic Cancer in Egypt
$76,500University Of Michigan At Ann Arbor · R03 · FY2003 · CA
Role of atypical PKCs in Pancreatic Tumor Growth and Metastasis
$76,500Nicole R Murray · Mayo Clinic Jacksonville · R03 · FY2010 · CA
A new curcumin analogue with potent suppressive activity in pancreatic cancer
$76,320Jiayuh Lin · Research Inst Nationwide Children'S Hosp · R03 · FY2009 · CA
A new curcumin analogue with potent suppressive activity in pancreatic cancer
$76,320Jiayuh Lin · Research Inst Nationwide Children'S Hosp · R03 · FY2010 · CA
Multiplex 'Conditional' Mice for Rapid and Affordable Pre-clinical Testing
$76,208Branden S Moriarity · University Of Minnesota · R03 · FY2017 · CA
Omega-3 Fatty Acid Effects on Pancreatitis and Adenocarcinoma Development
$76,161Christopher A Jolly · University Of Texas At Austin · R03 · FY2012 · CA
Targeting the let-7-HMGA2 Network in Metastatic Progression in Pancreatic Cancer
$76,140Linda M S Resar · Johns Hopkins University · R03 · FY2013 · CA
Cancer Prevention and Control
$76,066Todd C. Skaar · Indiana University Indianapolis · P30 · FY2025 · CA
DIFFUSION MRI TO ASSESS PANCREATIC TUMOR RESPONSE
$76,000Edgar Ben-Josef · University Of Michigan At Ann Arbor · R03 · FY2009 · CA
Identification of pancreatic cancer specific high affinity targeting ligands
$76,000Pappanaicken Rangasamy Kumaresan · University Of California At Davis · R03 · FY2008 · CA
Multiplex 'Conditional' Mice for Rapid and Affordable Pre-clinical Testing
$76,000Branden S Moriarity · University Of Minnesota · R03 · FY2016 · CA
DIFFUSION MRI TO ASSESS PANCREATIC TUMOR RESPONSE
$76,000Edgar Ben-Josef · University Of Michigan At Ann Arbor · R03 · FY2008 · CA